Illuminating Notch receptor-ligand selectivity through structure-guided protein engineering

通过结构引导的蛋白质工程阐明Notch受体-配体选择性

基本信息

项目摘要

PROJECT SUMMARY Overall vision of the research program. My research is focused on understanding the “molecular language” of cell-to-cell communication. Cell surface receptors transmit signals in response to external cues, and receptor activity is regulated by extrinsic factors such as posttranslational modifications, mechanical force, and chemical environment. Using a multidisciplinary approach that leverages my training in structural biology, biophysics, and protein engineering, my group is attempting to solve difficult problems in the area of receptor biology. We hypothesize that the distinct structural and biophysical parameters governing receptor-ligand interactions control downstream signaling, and that ligands may be engineered to alter these parameters and reprogram signaling outputs. My long-term goal is to harness the insight obtained through our mechanistic studies to design proteins that can fine-tune receptor activity and function as powerful next-generation therapeutics. Overview of research in the laboratory. Notch signaling is initiated when a mechanosensory Notch receptor is “pulled on” by a Delta-like (DLL) or Jagged (Jag) ligand expressed on an adjacent cell. In mammals, the various Notch receptor (Notch1-4) and ligand (DLL1, DLL4, Jag1, Jag2) subtypes are able to induce distinct or even opposing cellular responses. Ligand selectivity is further regulated by Notch receptor glycosylation, which inhibits the activity of Jag ligands yet potentiates the activity of DLL ligands. We currently have a poor understanding of the molecular basis for ligand discrimination in the Notch pathway, and structural studies of Notch receptor-ligand interactions have been difficult because their nearly undetectable binding affinity precludes reconstitution of stable complexes. We recently overcame this obstacle by using directed evolution to strengthen DLL4 and Jag1 binding to Notch1, which allowed us to capture their interacting domains for x-ray crystal structure determination. My lab is now building upon these transformative results to explore how the structural, biophysical, and mechanical properties of various ligand subtypes contribute to their unique functions. Goals for the next five years. Over the five-year funding period, the goals of this project are to: (i) systematically characterize the structure, binding kinetics, and signaling potency of Notch receptor-ligand complexes; (ii) use electron microscopy to visualize the ultrastructural architecture of full-length Notch1-DLL4 and Notch1-Jag1 complexes; (iii) determine the biophysical basis by which Notch glycosylation regulates DLL and Jag activity, and (iv) design tissue-specific Notch antagonists. The successful completion of this work will establish the molecular mechanisms of Notch receptor-ligand selectivity and will guide the engineering of novel modulators of Notch signaling with expanded capabilities in a variety of biological and therapeutic contexts.
项目概要 研究计划的总体愿景。我的研究重点是理解“分子语言” 细胞间的通讯。细胞表面受体响应外部信号传递信号,受体 活性受翻译后修饰、机械力和化学作用等外在因素调节 环境。采用多学科方法,利用我在结构生物学、生物物理学和 蛋白质工程,我的小组正在尝试解决受体生物学领域的难题。我们 假设控制受体-配体相互作用的不同结构和生物物理参数 下游信号传导,并且可以设计配体来改变这些参数并重新编程信号传导 输出。我的长期目标是利用通过我们的机制研究获得的见解来设计蛋白质 它可以微调受体活性并作为强大的下一代疗法发挥作用。 实验室研究概述。当机械感觉 Notch 受体出现时,Notch 信号传导就会启动。 被邻近细胞上表达的 Delta 样 (DLL) 或锯齿状 (Jag) 配体“拉动”。在哺乳动物中, 各种Notch受体(Notch1-4)和配体(DLL1、DLL4、Jag1、Jag2)亚型能够诱导不同的或 甚至相反的细胞反应。配体选择性进一步受到 Notch 受体糖基化的调节, 抑制 Jag 配体的活性,但增强 DLL 配体的活性。我们现在有一个贫困的 了解Notch途径中配体辨别的分子基础,以及结构研究 Notch受体-配体相互作用一直很困难,因为它们的结合亲和力几乎无法检测到 稳定复合物的重建。我们最近通过使用定向进化来加强克服了这个障碍 DLL4 和 Jag1 与 Notch1 结合,这使我们能够捕获它们的相互作用域以获取 X 射线晶体结构 决心。我的实验室现在正在这些变革性成果的基础上探索结构、生物物理、 各种配体亚型的机械性能和机械性能有助于其独特的功能。 未来五年的目标。在五年资助期内,该项目的目标是:(i)系统地 表征Notch受体-配体复合物的结构、结合动力学和信号传导效力; (二) 使用 电子显微镜可视化全长 Notch1-DLL4 和 Notch1-Jag1 的超微结构 复合体; (iii)确定Notch糖基化调节DLL和Jag活性的生物物理基础, (iv) 设计组织特异性Notch拮抗剂。这项工作的成功完成将建立 Notch受体-配体选择性的分子机制,并将指导新型调节剂的工程设计 Notch 信号传导在各种生物和治疗环境中具有扩展的功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vincent Christopher Luca其他文献

Vincent Christopher Luca的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vincent Christopher Luca', 18)}}的其他基金

Illuminating Notch receptor-ligand selectivity through structure-guided protein engineering
通过结构引导的蛋白质工程阐明Notch受体-配体选择性
  • 批准号:
    10727696
  • 财政年份:
    2019
  • 资助金额:
    $ 3.17万
  • 项目类别:
Illuminating Notch receptor-ligand selectivity through structure-guided protein engineering
通过结构引导的蛋白质工程阐明Notch受体-配体选择性
  • 批准号:
    10647862
  • 财政年份:
    2019
  • 资助金额:
    $ 3.17万
  • 项目类别:
Illuminating Notch receptor-ligand selectivity through structure-guided protein engineering
通过结构引导的蛋白质工程阐明Notch受体-配体选择性
  • 批准号:
    10189660
  • 财政年份:
    2019
  • 资助金额:
    $ 3.17万
  • 项目类别:
Illuminating Notch receptor-ligand selectivity through structure-guided protein engineering
通过结构引导的蛋白质工程阐明Notch受体-配体选择性
  • 批准号:
    9797167
  • 财政年份:
    2019
  • 资助金额:
    $ 3.17万
  • 项目类别:
Illuminating Notch receptor-ligand selectivity through structure-guided protein engineering
通过结构引导的蛋白质工程阐明Notch受体-配体选择性
  • 批准号:
    10640633
  • 财政年份:
    2019
  • 资助金额:
    $ 3.17万
  • 项目类别:
Illuminating Notch receptor-ligand selectivity through structure-guided protein engineering
通过结构引导的蛋白质工程阐明Notch受体-配体选择性
  • 批准号:
    10388928
  • 财政年份:
    2019
  • 资助金额:
    $ 3.17万
  • 项目类别:
Illuminating Notch receptor-ligand selectivity through structure-guided protein engineering
通过结构引导的蛋白质工程阐明Notch受体-配体选择性
  • 批准号:
    10426112
  • 财政年份:
    2019
  • 资助金额:
    $ 3.17万
  • 项目类别:
Deconstructing the molecular mechanisms of Notch receptor-ligand selectivity
解构Notch受体-配体选择性的分子机制
  • 批准号:
    9088914
  • 财政年份:
    2016
  • 资助金额:
    $ 3.17万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 3.17万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 3.17万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 3.17万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 3.17万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 3.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 3.17万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 3.17万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 3.17万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 3.17万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 3.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了